Local therapy using curcumin for treating Inflammatory Bowel Disease
Strategy for Safe Colon-targeted Local Therapy of Inflammatory Bowel Disease
This study is looking at a new way to help people with Inflammatory Bowel Disease (IBD) by using curcumin, a natural anti-inflammatory, directly where it's needed in the colon, which could make it work better and have fewer side effects than regular medications.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | South Dakota State University NIH-funded |
| Lab location | 1 site (Brookings, United States) |
| Project ID | NIH-10202303 on NIH RePORTER |
What this research studies
This research investigates a new approach to treat Inflammatory Bowel Disease (IBD) by delivering curcumin, a natural anti-inflammatory compound, directly to the inflamed areas of the colon. The goal is to improve the effectiveness of curcumin, which has been limited by its poor absorption in the body. By targeting the treatment locally, the researchers aim to reduce the side effects associated with systemic medications and provide a safer alternative for patients who do not respond to traditional therapies. This innovative method could potentially enhance the management of IBD and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Inflammatory Bowel Disease, particularly those who have not responded well to existing anti-inflammatory treatments.
Not a fit: Patients with mild forms of IBD or those who are currently responding well to existing treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer and more effective treatment option for patients suffering from Inflammatory Bowel Disease.
How similar studies have performed: While there have been challenges in previous studies with curcumin, this localized delivery approach is novel and has not been extensively tested in the context of IBD.
Where this research is happening
Brookings, United States
- South Dakota State University — Brookings, United States (Active)
Researchers
- Principal investigator: Tummala, Hemachand — South Dakota State University
- Study coordinator: Tummala, Hemachand
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.